Virtual ground-breaking of the expanded manufacturing facility of consumables; Strategic partnership with Zhifei Longcom Biologic Pharmacy to improve process of vaccine development; Accelerated collaboration with Clover Biopharmaceuticals to support the scale-up of its protein-based COVID-19 S-Trimer subunit vaccine candidate; Joint lab to be set up with Jinbo Bio-Pharmaceutical to advance industry innovation. Cytiva, a global […]

New RNA Spatial Profiling Service Allows Researchers to Access Advanced Technology and Extensive RNA Expertise in a Commercial Lab Setting MOUNTAIN VIEW, Calif.— Cellecta, Inc. today announced the launch of its new RNA Spatial Profiling Service using NanoString’s GeoMx®Cancer Transcriptome Atlas (CTA) on the GeoMx Digital Spatial Profiler. As one of the few designated GeoMx […]

Company’s Innovative Spectral Cell Analysis Systems Fueling Advancements in Immunotherapy, Infectious Disease Research FREMONT, Calif. — Cytek Biosciences Inc., a leading provider of cell analysis instrumentation and solutions, today announced that it has closed a $120 million Series D funding round, co-led by RA Capital and Hillhouse Capital, with OrbiMed and LYFE Capital also participating. The investment will be used to expand Cytek’s […]

Caption. CytoSMART new fluorescence live-cell imager enables researchers to unravel cellular processes in real-time. Eindhoven, The Netherlands – Life Science Newswire – CytoSMART Technologies today announced its first fluorescence live-cell imager. The CytoSMART Lux3 FL is a small live-cell imaging microscope equipped with one brightfield and two fluorescent channels (green and red). The device enables […]

25 Trials Utilizing Mass Cytometry Initiated in 2020 SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that its mass cytometry technologies, including CyTOF® , Imaging Mass Cytometry (IMC), and Maxpar® Direct™, have been used in 113 National Clinical Trials listed […]

Addition of CRISPR and RNAi offerings to complement PerkinElmer’s life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine WALTHAM, Mass. —  PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Horizon Discovery Group plc (LSE: HZD) (“Horizon”) are pleased to announce that they have reached an agreement on the terms of a recommended […]

The StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 Dyes offer maximal brightness for improved resolution HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today launched three StarBright Dyes specifically developed for flow cytometry. StarBright Blue 700, StarBright Violet 440, […]

Illkirch, FRANCE – Polyplus-transfection® SA (“Polyplus”), the leading biotechnology company that supports the gene and cell therapy market by supplying innovative transfection solutions, today named Mario Philips as Chief Executive Officer (“CEO”). Mr. Philips succeeds Karsten Wilking, who will transition into a Strategic Advisor role. In addition, Polyplus has named Dr. Andreas Rummelt and Jean-Paul […]

Amsterdam, the Netherlands — 30 October 2020 — LUMICKS is pleased to announce a collaboration agreement with clinical-stage biotech company Leucid Bio, which seeks to utilize LUMICKS’ z-Movi® Cell Avidity Analyzer (z-Movi) to accelerate entry of immunotherapeutic candidates into clinical trials. The goal of the partnership is to evaluate the efficacy of Leucid Bio’s next-generation chimeric antigen receptor (CAR) T-cells using the […]

By combining two assays in a single platform, the integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs SOUTH SAN FRANCISCO, Calif. — Mission Bio, Inc. today announced the launch of a complete Tapestri® Single-cell Multi-omics Solution, the most comprehensive single-cell multi-omics platform on the market. With a new […]